EFFECT OF ALPHA-1-PROTEINASE INHIBITOR ON NEUTROPHIL CHEMOTAXIS

被引:51
|
作者
STOCKLEY, RA
SHAW, J
AFFORD, SC
MORRISON, HM
BURNETT, D
机构
[1] Lung Immunobiochemical Research Laboratory, General Hospital, Birmingham
关键词
D O I
10.1165/ajrcmb/2.2.163
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Factors that modulate neutrophil migration into the lung are poorly understood. However, there is evidence that neutrophil activation by formylmethionylleucylphenylalanine (FMLP) depends upon a surface proteinase with chymotrypsin-like activity. This suggests that chymotrypsin inhibitors such as alpha-1-proteinase inhibitor (alpha 1PI) could modify neutrophil migration in response to FMLP. We have studied neutrophil chemotaxis using the multiple blind well assay system. This article presents evidence that alpha 1PI is an inhibitor of neutrophil migration in response to FMLP. The effect is related to the inhibitory function of the protein. Alpha-1-antichymotrypsin is more potent than alpha 1PI as an inhibitor of this movement, whereas antileukoprotease is less potent. The results suggest that a cell membrane-bound serine proteinase (perhaps cathepsin G) is necessary for the enhancement of cell movement after receptor binding of FMLP. Oxidized alpha 1PI or a 4,000-D peptide cleaved from alpha 1PI by porcine pancreatic elastase or human neutrophil elastase are capable of enhancing cell motility. The results suggest that alpha 1PI may play a role in cell migration into the lung during acute inflammatory process.
引用
收藏
页码:163 / 170
页数:8
相关论文
共 50 条
  • [21] AORTIC-ANEURYSMS AND ALPHA-1-PROTEINASE INHIBITOR
    POWELL, JT
    CAMPA, J
    MULLER, BR
    STARKIE, R
    GREENHALGH, RM
    BRITISH JOURNAL OF SURGERY, 1985, 72 (05) : 401 - 401
  • [22] MODELING THE INTACT FORM OF THE ALPHA-1-PROTEINASE INHIBITOR
    ENGH, RA
    WRIGHT, HT
    HUBER, R
    PROTEIN ENGINEERING, 1990, 3 (06): : 469 - 477
  • [23] INTERACTION OF HUMAN ALPHA-1-PROTEINASE INHIBITOR WITH TRYPSIN
    TRAVIS, J
    PANNELL, R
    JOHNSON, D
    FEDERATION PROCEEDINGS, 1974, 33 (05) : 1563 - 1563
  • [24] OZONE INACTIVATION OF HUMAN ALPHA-1-PROTEINASE INHIBITOR
    JOHNSON, DA
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1980, 121 (06): : 1031 - 1038
  • [25] Pharmacokinetics of alpha-1-proteinase inhibitor in premature infants
    Ito, S
    Dunn, M
    Stiskal, J
    O'Brien, K
    Cox, DW
    Kelly, E
    Shennan, A
    Newman, C
    Wylie, L
    Hanna, K
    Saunders, G
    Rabinovitch, M
    PEDIATRIC RESEARCH, 2000, 47 (04) : 471A - 471A
  • [26] INHIBITORY MECHANISM OF HUMAN ALPHA-1-PROTEINASE INHIBITOR
    JOHNSON, DA
    TRAVIS, J
    FEDERATION PROCEEDINGS, 1976, 35 (07) : 1463 - 1463
  • [27] ALPHA-1-PROTEINASE INHIBITOR PHENOTYPES IN PORTUGUESE POPULATION
    ROSA, MAS
    CORDEIRO, AJAR
    EUROPEAN JOURNAL OF RESPIRATORY DISEASES, 1986, 69 : A147 - A147
  • [28] ALPHA-1-PROTEINASE INHIBITOR PHENOTYPES IN PRETERM NEWBORNS
    BASYS, V
    NASLIUNIENE, A
    PEDIATRIC RESEARCH, 1989, 26 (05) : 516 - 516
  • [29] DETERMINATION OF OXIDIZED ALPHA-1-PROTEINASE INHIBITOR IN SERUM
    BEATTY, K
    ROBERTIE, P
    SENIOR, RM
    TRAVIS, J
    JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1982, 100 (02): : 186 - 192
  • [30] RAPID SCREENING FOR DEFICIENCY OF ALPHA-1-PROTEINASE INHIBITOR
    LLOYD, C
    TRAVIS, J
    CLINICAL CHEMISTRY, 1989, 35 (09) : 1971 - 1975